Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:LBIO’

test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

Is Lion Biotechnologies Inc (LBIO) About to Roar?

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors......(read more)
Most Advanced Countries in Medicine

Is Lion Biotechnologies Inc (LBIO) A Good Stock To Buy?

The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by......(read more)

Trellus Management’s Top Biotech Stock Picks For Q4

Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994. The fund manages client focused equity portfolios and......(read more)
Broadfin Kevin Kotler

Alere Inc (ALR), Lion Biotech (LBIO), Genocea Biosciences Inc (GNCA), Advaxis Inc (ADXS) Among Broadfin’s Top New Health Picks

Broadfin Capital, LLC is a New York-based hedge fund, whose $1.28-billion equity portfolio is invested in healthcare companies. Kevin Kotler, a University......(read more)

Lion Biotechnologies Inc (LBIO): Ayer Capital Management Halves Its Stake

Biotech stocks have been in the middle of everyone’s attention lately and many have gained impressive ground (often not justified by the company......(read more)